Mark Glassner
Family Medicine · Newark, DENPI 1396746293
Payments from drug & device makers
Across 82 payments — averaging $14.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$433
- Astellas Pharma US Inc$73
- AbbVie$72
- Idorsia Pharmaceuticals US Inc$67
- Novo Nordisk$66
- AstraZeneca$62
- plus $391 from 15 others
What the payments were for
- Food & beverage$1,163100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 38 | $433 |
| Astellas Pharma US Inc | 5 | $73 |
| AbbVie | 2 | $72 |
| Idorsia Pharmaceuticals US Inc | 4 | $67 |
| Novo Nordisk | 4 | $66 |
| AstraZeneca | 4 | $62 |
| Merck | 4 | $53 |
| Exact Sciences | 2 | $48 |
| Amgen | 2 | $37 |
| Lilly USA, LLC | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $29 |
| Genentech USA, Inc. | 2 | $28 |
| Seqirus USA Inc | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Boehringer Ingelheim | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Bausch Health US, LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| GSK | 1 | $13 |
How this compares
$1,163 in reported general payments places this provider in the 70th percentile of 352 family medicine providers in Delaware.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 13 | $21,503 |
| JanuviaSitagliptin Phosphate | 12 | $13,846 |
| Spiriva HandihalerTiotropium Bromide | 15 | $9,567 |
| Atorvastatin Calcium | 217 | $2,815 |
| Omeprazole | 85 | $1,479 |
| Esomeprazole Magnesium | 21 | $1,252 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 26 | $1,188 |
| Levothyroxine Sodium | 117 | $1,154 |
| Gabapentin | 32 | $1,048 |
| Rosuvastatin Calcium | 46 | $966 |
| Buspirone Hcl | 21 | $942 |
| Metformin Hcl | 111 | $930 |
| Trazodone Hcl | 42 | $868 |
| Losartan Potassium | 65 | $829 |
| Metoprolol Succinate | 50 | $804 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $433 | $21,50313 claims |
| MerckJanuvia | $53 | $13,84612 claims |
| Lilly USA, LLCOlanzapine | $35 | $19423 claims |
| AbbVieSynthroid | $72 | $9111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 352 family medicine providers in Delaware.
Other family medicine in Newark
- Michelle PapaNewark$23K
- Ian MyersNewark$17K
- Robert WinterNewark$12K
- Judy LimNewark$12K
- Huy leNewark$10K
- Arlen StoneNewark$10K
- Imelyn LaheyNewark$8K
- Angela Davis BrownNewark$8K
- Robert CallahanNewark$7K
- George NameyNewark$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.